Community Network Program

This study is currently recruiting participants.
Verified October 2013 by M.D. Anderson Cancer Center
Sponsor:
Collaborator:
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT01504919
First received: January 3, 2012
Last updated: October 22, 2013
Last verified: October 2013
  Purpose

The goal of this research study is to learn if a wellness program can help improve diet and physical activity levels and encourage smoking cessation in Latino individuals who are overweight.


Condition Intervention
Psychosocial Problem
Behavioral: Health Education
Behavioral: Questionnaires
Behavioral: Telephone Counseling Sessions
Drug: Nicotine Patches

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: Reducing Cancer Disparities Among Latinos in Texas

Resource links provided by NLM:


Further study details as provided by M.D. Anderson Cancer Center:

Primary Outcome Measures:
  • Efficacy of Motivation and Problem Solving (MAPS) in Cancer Risk Reduction [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    Generalized linear mixed model regression (GLMM) used in analyzing the effects of motivation and problem solving (MAPS) on the primary outcomes across the 6, 12, and 18-month time points.


Estimated Enrollment: 500
Study Start Date: January 2012
Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Health Education (HE)
HE of brief counseling and self-help materials addressing 3 risk behaviors, referrals to available resources, and a home-based exercise kit; 6-week supply of nicotine patches for smoking cessation if needed.
Behavioral: Health Education
Brief counseling at baseline, at 6 months and again at 12 months, and self-help materials addressing smoking cessation, diet, physical activity, referrals to available resources, and a home-based exercise kit (e.g., pedometer, exercise ball, strength training cables).
Behavioral: Questionnaires
Computer-based questionnaires completed at baseline, then every 6 months taking 60-90 minutes to complete.
Other Name: surveys
Drug: Nicotine Patches
6-week supply of nicotine patches given to participants ready to quit smoking.
Experimental: Motivation and Problem Solving (MAPS)
HE counseling, self-help materials, and resource referrals, and home-based exercise kit; 6-week supply of nicotine patches for smoking cessation if needed. Plus 9 proactive, telephone counseling sessions over the 18 month period.
Behavioral: Health Education
Brief counseling at baseline, at 6 months and again at 12 months, and self-help materials addressing smoking cessation, diet, physical activity, referrals to available resources, and a home-based exercise kit (e.g., pedometer, exercise ball, strength training cables).
Behavioral: Questionnaires
Computer-based questionnaires completed at baseline, then every 6 months taking 60-90 minutes to complete.
Other Name: surveys
Behavioral: Telephone Counseling Sessions
9 proactive, telephone counseling sessions over 18 months. Each of these phone calls should last about 20-30 minutes.
Other Name: Counseling
Drug: Nicotine Patches
6-week supply of nicotine patches given to participants ready to quit smoking.

  Hide Detailed Description

Detailed Description:

Day 1 Study Visit:

If you are found eligible to take part in this study, the following tests and procedures will be performed on Day 1 (the same day you complete the screening tests and sign this consent form):

  • You will be asked to complete some computer-based questionnaires or paper/pencil questionnaires that will include questions about your feelings, moods, and smoking status. These will take 60-90 minutes to complete.
  • You will have your height, weight, and waistline measured.
  • Your blood pressure will be measured by a trained research staff member
  • You will complete a breath test to help researchers estimate (guess) the amount of cigarette smoke you inhale. The breath test uses a disposable cardboard tube that is attached to a machine, and you will be asked to blow a long, slow, steady breath into it.
  • You will be given an accelerometer to wear for 7 days. An accelerometer is a small device that is worn on the waistline of your pants that measures your level of physical activity. After 7 days, you will be asked to "turn off" and mail back the accelerometer using a prepaid envelope provided by the study staff.
  • You will give a saliva sample at this visit. To collect the saliva sample, you will place a piece of cotton in your mouth for 3 minutes. The saliva sample is used to check the amount of cotinine in the body. Cotinine is a chemical that is produced in your saliva when your body breaks down nicotine.

Study Groups and Study Procedures:

At the Day 1 study visit, you will be randomly assigned (as in the flip of a coin) into 1 of 2 study groups. There is an equal chance of being assigned to either group.

Participants in both groups will receive health education on Day 1, and again 6 and 12 months later. You can also ask to receive a 6-week supply of nicotine patches, whenever you are ready to try to quit smoking and a home-based exercise kit when you are ready to begin an exercise program.

At the Day 1 health education session, the following will take place:

  • You will have a brief counseling session with a study staff member to talk about smoking, diet, and your physical activity level.
  • You will be offered referrals to available resources for help with your smoking cessation, diet, and physical activity.
  • You will be given a home-based exercise kit, along with self-help materials that are designed to help you learn how to quit smoking and how to improve your diet and physical activity.

At the Months 6 and 12 health education sessions, the Day 1 activities will be repeated, and the following procedures will also take place:

  • You will complete a computer-based or paper/pencil questionnaire about your mood, diet, and physical activity. This will take 60-90 minutes to complete.
  • Your weight and waistline will be measured.
  • You will complete a breath test. The breath test uses a disposable cardboard tube that is attached to a machine, and you will be asked to blow a long, slow, steady breath into it.
  • You will give a saliva sample. To collect the saliva sample, you will place a piece of cotton in your mouth for 3 minutes. The saliva sample is used to check the amount of cotinine in the body. Cotinine is a chemical that is produced in your saliva when your body breaks down nicotine.
  • You will be given an accelerometer to wear for 7 days. After 7 days, you will mail back the accelerometer using a prepaid envelope provided by the study staff.

You will also have a follow-up study visit at Month 18. During this visit, the same procedures from the Month 12 visit will be performed. However, you will not have a health education session at Month 18.

Wellness Program:

In addition to the health education visits and materials, participants in Group 2 will also take part in the wellness program. For the wellness program, you will receive 18 counseling phone calls over the 18 months you are on study. Each of these phone calls should last about 20-30 minutes.

The telephone counseling sessions will be digitally recorded. Audio recordings will be erased once the data have been published. The recordings will be used to help the researchers make sure that the counselors are following the correct procedures and may be used in the future to help the researchers better understand or improve the counseling treatment. No one but the researchers and their staff will be allowed to view or listen to the recordings, and the identity of the participants will be kept strictly confidential. Your study identification number will be stated by the counselor at the beginning of the taped session. The recordings are stored digitally, encrypted, and password protected.

Questionnaire Data:

Your questionnaire data will be used for research purposes only. Your responses will not be shared with your doctor. If you feel you need a doctor's opinion about anything that is asked about in the questionnaires (such as mental or emotional difficulties or symptoms), please contact either your personal doctor or the study chair.

Length of Study:

You will remain on the study for up to 18 months. Your participation on this part of the study will be over once you complete the study visit at Month 18.

This is an investigational study. The nicotine patch is FDA approved and commercially available. Up to 500 participants overall will take part in this research study. Up to 400 participants will take part in this portion of the study. All will be enrolled at MD Anderson.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Latino adults
  2. 18 years of age or older
  3. Current smoker with a history of smoking an average of at least 1 cigarette per day during the last year
  4. Overweight/obese (BMI greater than or equal to 25)
  5. Functioning telephone number
  6. Valid home address
  7. Ability to engage in low to moderate physical activity as determined by the Physical Activity Readiness Questionnaire (PAR-Q)
  8. Blood Pressure readings <140/90 mm Hg as defined by the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; Pressure readings >/=140/90 mm Hg will be deemed ineligible to participate and excluded from the study. They will be referred to their family physician or community services. Those ineligible based on their initial blood pressure reading are allowed to participate if they provide a letter from a physician who will continue to monitor the participant during the research study.
  9. Can speak, read, and understand Spanish and/or English

Exclusion Criteria:

  1. Pregnancy or lactation
  2. Participants who were recruited for the pilot and focus groups are not eligible for the randomized trial.
  3. Contraindication for nicotine patch use
  4. Regular use of tobacco products
  5. Current use of tobacco cessation medications
  6. Currently enrolled in another smoking cessation study
  7. Another household member enrolled in the study
  8. Scores below 38 on the Short Assessment of Health Literacy for Spanish Adults (SAHLSA)
  9. Active substance abuse or dependence
  10. Scores below the 6th grade literacy level on the Rapid Estimate of Adult Literacy in Medicine (REALM)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01504919

Contacts
Contact: Shanna Barnett, MPH, MBA, DRPH 713-792-5807 sbarnett@mdanderson.org

Locations
United States, Texas
UT MD Anderson Cancer Center Recruiting
Houston, Texas, United States, 77030
Sponsors and Collaborators
M.D. Anderson Cancer Center
Investigators
Principal Investigator: David Wetter, PHD, MS, BA UT MD Anderson Cancer Center
  More Information

Additional Information:
No publications provided by M.D. Anderson Cancer Center

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier: NCT01504919     History of Changes
Other Study ID Numbers: 2010-0606
Study First Received: January 3, 2012
Last Updated: October 22, 2013
Health Authority: United States: Institutional Review Board
United States: Federal Government

Keywords provided by M.D. Anderson Cancer Center:
Psychosocial
Behavioral intervention
Nicotine patch
Latinos
Mexican American
Motivation and Problem Solving
MAPS
Cancer risk reduction
Smoking cessation
Overweight/obese smokers
BMI greater than or equal to 25
Wellness program
Questionnaires
Surveys
Self-help materials
Pamphlets

Additional relevant MeSH terms:
Nicotine
Nicotine polacrilex
Ganglionic Stimulants
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Pharmacologic Actions
Nicotinic Agonists
Cholinergic Agonists
Cholinergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Central Nervous System Stimulants
Central Nervous System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on April 16, 2014